S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
3rd Massive Dollar Upheaval Has Started (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden's Plan to Confiscate Your Cash? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
3rd Massive Dollar Upheaval Has Started (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden's Plan to Confiscate Your Cash? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
3rd Massive Dollar Upheaval Has Started (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden's Plan to Confiscate Your Cash? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
3rd Massive Dollar Upheaval Has Started (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Biden's Plan to Confiscate Your Cash? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
NYSEARCA:FXE

Invesco CurrencyShares Euro Trust - FXE Stock Forecast, Price & News

$94.16
+0.10 (+0.11%)
(As of 08/8/2022 12:00 AM ET)
Add
Today's Range
$94.13
$94.44
50-Day Range
$92.60
$99.47
52-Week Range
$92.03
$111.02
Volume
26,073 shs
Average Volume
117,625 shs
Market Capitalization
$329.56 million
P/E Ratio
N/A
Dividend Yield
0.00%
Price Target
N/A
Receive FXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco CurrencyShares Euro Trust and its competitors with MarketBeat's FREE daily newsletter.

Receive FXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco CurrencyShares Euro Trust and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Invesco
Fund NameInvesco CurrencyShares Euro Trust
Tax ClassificationGrantor Trust
SymbolNYSEARCA:FXE
Inception Date12/9/2005
Fund Manager

Fund Focus

Asset ClassCurrency
BenchmarkEuro
CategoryEuro
FocusEuro
Development LevelDeveloped Markets
RegionEurope

Fund Statistics

Assets Under Management$289.09 million
Average Daily Volume$144,033.40
Discount/Premium0.09%

ETF Expenses

Management Fee0.40%
Other Expenses0.00%
Total Expenses0.40%
Fee Waiver0.00%
Net Expenses0.40%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Specialized Sponsors, LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
TrusteeThe Bank of New York Mellon Corporation
Lead Market MakerCitadel














FXE Stock - Frequently Asked Questions

How has Invesco CurrencyShares Euro Trust's stock price performed in 2022?

Invesco CurrencyShares Euro Trust's stock was trading at $105.76 at the start of the year. Since then, FXE stock has decreased by 11.0% and is now trading at $94.16.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Invesco CurrencyShares Euro Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco CurrencyShares Euro Trust investors own include Wells Fargo & Company (WFC), Netflix (NFLX), NVIDIA (NVDA), SPDR S&P 500 ETF Trust (SPY), Bank of America (BAC), Intel (INTC), JPMorgan Chase & Co. (JPM), Gilead Sciences (GILD), Home Depot (HD) and Starbucks (SBUX).

What is Invesco CurrencyShares Euro Trust's stock symbol?

Invesco CurrencyShares Euro Trust trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FXE."

Who are Invesco CurrencyShares Euro Trust's major shareholders?

Invesco CurrencyShares Euro Trust's stock is owned by a number of retail and institutional investors. Top institutional investors include Leuthold Group LLC (1.19%), Upper Left Wealth Management LLC (1.54%), Saxon Interests Inc. (0.30%), Abundance Wealth Counselors (0.14%), GFS Advisors LLC (0.08%) and Westside Investment Management Inc. (0.08%).

How do I buy shares of Invesco CurrencyShares Euro Trust?

Shares of FXE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invesco CurrencyShares Euro Trust's stock price today?

One share of FXE stock can currently be purchased for approximately $94.16.

How much money does Invesco CurrencyShares Euro Trust make?

Invesco CurrencyShares Euro Trust (NYSEARCA:FXE) has a market capitalization of $329.56 million.

How can I contact Invesco CurrencyShares Euro Trust?

Invesco CurrencyShares Euro Trust's mailing address is 805 King Farm Boulevard, Suite 600, ROCKVILLE, MD 20850, United States. The official website for the company is www.currencyshares.com. The exchange traded fund can be reached via phone at +1-800-8200888.

This page (NYSEARCA:FXE) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.